Benign hyperplasia of the prostate causing bladder outlet obstruction is one of the most common maladies afflicting older men, but little is known concerning its pathogenesis. There is considerable histologic diversity in the composition of hyperplastic tissue which may indicate individual patient differences in the etiology or pathogenesis of BPH, with some cases comprised primarily of stroma, and other cases containing mostly glandular epithelium and lumenal volume. Using immunohistochemistry to specifically identify the components of the tissue and quantitative morphometric techniques we will correlate the amount of each of the major tissue components with clinical factors including patient age and duration and severity of symptoms. Using specific antibodies against proteins expressed only during the mitotic cycle we can determine the correlation of proliferative indices to tissue histology and patient symptoms. The presence and distribution of hormone receptors (estrogen, progesterone, and androgen) and certain growth factors and their receptors will also be determined and quantified. Also, we will be able to determine the effects of various treatment modalities including anti-androgen therapy, alpha-adrenergic blockade, and transurethral incision of the prostate on the tissue components and proliferative indices in patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045761-03
Application #
2145004
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1992-09-30
Project End
1996-09-29
Budget Start
1994-09-30
Budget End
1996-09-29
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Washington
Department
Urology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Yu, E Y; Siegal, J A; Meyer, G E et al. (1997) Histologic differences in benign prostate hyperplasia between Chinese and American men. Prostate 31:175-9
Martensson, S; Bigler, S A; Brown, M et al. (1995) Sialyl-Lewis(x) and related carbohydrate antigens in the prostate. Hum Pathol 26:735-9
Siegal, J A; Yu, E; Brawer, M K (1995) Topography of neovascularity in human prostate carcinoma. Cancer 75:2545-51
Deering, R E; Bigler, S A; Brown, M et al. (1995) Microvascularity in benign prostatic hyperplasia. Prostate 26:111-5
Meyer, G E; Yu, E; Siegal, J A et al. (1995) Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 76:2304-11
Deering, R E; Bigler, S A; King, J et al. (1994) Morphometric quantitation of stroma in human benign prostatic hyperplasia. Urology 44:64-70
Brawer, M K; Aramburu, E A; Chen, G L et al. (1993) The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 150:369-73